Sophia Ambruso, DO

Associate Professor, Medicine-Renal Med Diseases/Hypertension


FacultyPhoto
Medical School
  • DO, Kansas City University of Medicine and Biosciences College of Osteopathic Medicine (2011)
Undergraduate School
  • BA, Colorado College (CO) (2002)
Internship
  • University of Washington Program (2013)
Residency
  • University of Washington Program, Chief Resident, Internal Medicine (2016)
Fellowships
  • University of Colorado (University Hospital) Program, Nephrology (2018)
Department
Medicine-Renal Med Diseases/Hypertension

Professional Titles

  • Director, VAMC Renal Clinic
  • Director, VAMC Inpatient Dialysis

Publications

  • Ambruso SL, Weir MR. The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD. Kidney Int Rep. 2024 May 27;9(7):1960-1962. doi: 10.1016/j.ekir.2024.05.027. PMID: 39081722; PMCID: PMC11284431.
  • Rizzolo K, Beck NM, Ambruso SL. Syndromes of Pseudo-Hyperaldosteronism. Clin J Am Soc Nephrol. 2022 Feb 8:CJN.14201021. doi: 10.2215/CJN.14201021. Epub ahead of print. PMID: 35135780.
  • Ambruso SL, Teitelbaum I. Diabetes Secrets; Diabetic Kidney Disease. 1st ed. McDermott MT. Elsevier; 2021, pp.
  • Tomacruz ID, Teodosiu C, Ambruso SL, Lim M. The Nephrology social media collective internship: cultivating leaders in the age of social media. Kidney news. 2021
  • Ambruso SL. Is It Time to Rethink the Age-Old Practice of Permissive Hyperkalemia in Renin-Angiotensin-Aldosterone Inhibition?. Kidney Int Rep. 2021 May;6(5):1203-1204. PubMed PMID: 34015068

Practice Locations

Hospital Affiliation
  • Veterans Affairs Medical Center

Specialty Information

Specialties
  • Nephrology, Board Certification (2018, 2018)